Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haynes

Showing results (471-480 of 843) with videos related to

Pageof 85
Sort By:
Journal of Virology|December 23, 2011
Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophagesChristina Ochsenbauer, Tara G Edmonds, Haitao Ding, et al.
Drug and Alcohol Dependence|September 14, 2012
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trialBruce R Schackman, Lisa R Metsch, Grant N Colfax, et al.
Vaccine|August 19, 2004
A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaquesMichael A Egan, Siew Yen Chong, Michael Hagen, et al.
Plos One|August 31, 2011
A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivityMohammed Asmal, Ina Hellmann, Weimin Liu, et al.
Msphere|June 5, 2020
Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine TrialsEliza D Hompe, Jesse F Mangold, Amit Kumar, et al.
Journal of Virology|July 14, 2017
Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1Kening Wang, Georgia D Tomaras, Sinthujan Jegaskanda, et al.
Virology|November 20, 2009
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1Avishek Nandi, Christine L Lavine, Pengcheng Wang, et al.
Plos Pathogens|May 14, 2010
Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionHolger B Kramer, Kerry J Lavender, Li Qin, et al.
Science (New York, N.Y.)|April 30, 2005
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodiesBarton F Haynes, Judith Fleming, E William St Clair, et al.
Vaccine|May 16, 2002
Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSFHua Xin Liao, George J Cianciolo, Herman F Staats, et al.
Pageof 85

Showing results (471-480 of 843) with videos related to

Sort By:
Pageof 85
Journal of Virology|December 23, 2011
Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophagesChristina Ochsenbauer, Tara G Edmonds, Haitao Ding, et al.
Drug and Alcohol Dependence|September 14, 2012
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trialBruce R Schackman, Lisa R Metsch, Grant N Colfax, et al.
Vaccine|August 19, 2004
A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaquesMichael A Egan, Siew Yen Chong, Michael Hagen, et al.
Plos One|August 31, 2011
A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivityMohammed Asmal, Ina Hellmann, Weimin Liu, et al.
Msphere|June 5, 2020
Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine TrialsEliza D Hompe, Jesse F Mangold, Amit Kumar, et al.
Journal of Virology|July 14, 2017
Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1Kening Wang, Georgia D Tomaras, Sinthujan Jegaskanda, et al.
Virology|November 20, 2009
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1Avishek Nandi, Christine L Lavine, Pengcheng Wang, et al.
Plos Pathogens|May 14, 2010
Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionHolger B Kramer, Kerry J Lavender, Li Qin, et al.
Science (New York, N.Y.)|April 30, 2005
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodiesBarton F Haynes, Judith Fleming, E William St Clair, et al.
Vaccine|May 16, 2002
Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSFHua Xin Liao, George J Cianciolo, Herman F Staats, et al.
Pageof 85